Prof. DELORD is Director of the Centre de Lutte Contre le Cancer Claudius Regaud (Toulouse, France), where he heads the Early Phase Trial programs, the Clinical Research Unit, the Pharmacology Laboratory and the Medical Oncology Department. He is also director of the Institut Universitaire du Cancer Toulouse-Oncopole (IUCT-O, France).
Prof. DELORD’s research interests focus on the biology of ovarian cancer, head and neck cancer, the pharmacology of anticancer drugs, and the relationship between the tumor micro-environment and malignant cells. He is involved in preclinical programs for the development of new compounds from basic research to early clinical phases, pharmacokinetic, pharmacodynamic studies and “First in Human” trials.
He is a member of several scientific boards in the biotech and pharmaceutical industries, with valuable expertise in pre-clinical phases of development. He is a national expert of the Minister of Research and Industry.